EPIWORLD (02726) intends to repurchase the company's H shares.

EPIWORLD (02726) announces that the Board has resolved and approved the repurchase of H Shares by the Company on the public market of the Stock Exchange from time to time, subject to market conditions and the Company's actual circumstances, and within the scope of the general mandate granted to the Board by the shareholders at the Company's annual general meeting held on June 22, 2026. Pursuant to the Repurchase Mandate, the Company may repurchase up to 10% of the total number of issued and fully paid H Shares of the Company (excluding treasury shares (if any)) as at the date on which the Repurchase Mandate was approved, i.e. not more than 11.892 million H Shares. The Company intends to fund the H Share repurchases with its own funds. When repurchasing H Shares, the Company may only use funds legally available for such purpose in accordance with the Articles of Association, the Listing Rules, PRC laws and/or any other applicable laws (as the case may be). The total amount of funds proposed to be used for such repurchases shall not exceed HK$1.78 billion.